Progress of clinical therapies for dry age-related macular degeneration [PDF]
International Journal of Ophthalmology, 2022 Dry age-related macular degeneration (AMD) is a progressive blinding disease that currently affects millions of people worldwide with no successful treatment available.
Rhianna Rubner +2 more
doaj +5 more sources
Improvement in Dry Age-Related Macular Degeneration with Photobiomodulation. [PDF]
Case Rep OphthalmolIntroduction: This case report describes a finding of dramatic improvement in drusen volume and visual acuity in a 73-year-old patient diagnosed with dry age-related macular degeneration (AMD) undergoing daily home photobiomodulation alongside
Ji PX +3 more
europepmc +4 more sources
Long-Term Follow-Up of Dry Age-Related Macular Degeneration Patients. [PDF]
J Curr OphthalmolPurpose: To assess the progression rate from dry age-related macular degeneration (dAMD) to advanced AMD and possible risk factors. Methods: Demographics, medical and ocular conditions, baseline eye examinations, optical coherence tomography features ...
Sadeghi E +8 more
europepmc +2 more sources
Choriocapillaris Flow and Retinal Vascular Fractal Dimension in Dry Age-Related Macular Degeneration. [PDF]
Diagnostics (Basel)Background/Objective: To evaluate the association between optical coherence tomography angiography (OCTA)-derived choriocapillaris flow (CCflow), retinal vascular fractal dimension (FD), and drusen burden in eyes with dry age-related macular degeneration
Ozturk M, Ağın A.
europepmc +2 more sources
Multiwavelength Photobiomodulation Improves Multiple Aspects of Visual Function in Early-Stage Dry Age-Related Macular Degeneration. [PDF]
Ophthalmol TherIntroduction This study aimed to evaluate the safety and efficacy of multiwavelength photobiomodulation (PBM) treatment (Tx) in earlier stages of nonexudative (dry) age-related macular degeneration (AMD).
Küçükerdönmez C, Tedford SE.
europepmc +2 more sources
Antioxidants and Mechanistic Insights for Managing Dry Age-Related Macular Degeneration. [PDF]
Antioxidants (Basel)Age-related macular degeneration (AMD) severely affects central vision due to progressive macular degeneration and its staggering prevalence is rising globally, especially in the elderly population above 55 years. Increased oxidative stress with aging is
Basyal D, Lee S, Kim HJ.
europepmc +2 more sources
Human retinal organoids for modelling dry age-related macular degeneration and screening drugs. [PDF]
Genes DisAge-related macular degeneration (AMD) poses a significant threat to the vision of the elderly population globally. Unfortunately, there is no effective treatment available for dry AMD.
Hao X, Du L, Liu G, Li Z, Wang S.
europepmc +2 more sources
Dry age-related macular degeneration - therapeutic possibilities and research directions [PDF]
Farmacja Polska, 2022 Age-related macular degeneration (AMD) is a major cause of vision loss in developed countries, especially in the elderly population. AMD is a multifactorial disease which etiology is not completely understood.
Alicja Zajdel
doaj +1 more source
Response to "Letter to the Editor Regarding 'Multiwavelength Photobiomodulation Improves Multiple Aspects of Visual Function in Early-Stage Dry Age-Related Macular Degeneration'". [PDF]
Ophthalmol TherKüçükerdönmez C, Tedford SE.
europepmc +2 more sources
Treatment Methods Dry Form of Age Macular Degeneration — History and Prospects. Review
Oftalʹmologiâ, 2023 Age related macular degeneration is a leading cause of vision loss and an increasing problem of disability throughout the world among adults. That revue covers historical points, risk factors, pathogenesis, classification and current treatment ways of ...
A. N. Kulikov +2 more
doaj +1 more source